What are the recommended next steps for a 34‑year‑old female with Ehlers‑Danlos syndrome (EDS), mast cell activation syndrome (MCAS), postural orthostatic tachycardia syndrome (POTS), borderline low immunoglobulin G (IgG) and low‑normal immunoglobulin A (IgA), recurrent otitis media with tympanic membrane perforations, persistent oral ulceration, and non‑immune measles‑mumps‑rubella (MMR) measles and mumps titers?

Next Steps for Evaluation and Management

Given this patient's borderline low IgG (812 mg/dL), low-normal IgA (79 mg/dL), recurrent otitis media with complications, and failed MMR vaccine response, you should immediately assess specific antibody responses to both protein and polysaccharide antigens to determine if she has specific antibody deficiency (SAD) or evolving common variable immunodeficiency (CVID). 1

Immediate Laboratory Evaluation

Specific Antibody Testing (Priority)

• Measure antibody titers to protein antigens: Check tetanus, diphtheria, and measles/mumps/rubella titers to assess protein antigen response 1
• Measure antibody titers to polysaccharide antigens: Obtain pneumococcal antibody titers (preferably to 12-14 serotypes) to assess polysaccharide response 1
• If baseline titers are inadequate: Administer Pneumovax 23 and recheck titers 4-8 weeks later to assess vaccine response 1

Additional Immunologic Studies

• IgG subclasses: Measure all four IgG subclasses (IgG1, IgG2, IgG3, IgG4) given the recurrent respiratory infections and borderline total IgG 1
• Lymphocyte subset analysis: Obtain CD19+ B cell counts to help differentiate between antibody deficiency subtypes 1
• Repeat immunoglobulin levels: Confirm the low-normal values with at least one additional measurement at least 1 month apart 1

Diagnostic Considerations

Primary Immunodeficiency Assessment

The combination of borderline low IgG, low-normal IgA, recurrent otitis media with complications (TM perforations, bullous myringitis), and failed MMR vaccine response strongly suggests an underlying antibody deficiency disorder. 1, 2, 3

Key diagnostic possibilities include:

• Specific Antibody Deficiency (SAD): Normal or near-normal immunoglobulin levels but impaired specific antibody production, particularly to polysaccharide antigens 1
• IgG Subclass Deficiency (IGGSD): One or more IgG subclass levels below the 5th percentile with impaired vaccine responses 1
• Evolving CVID: Her IgG of 812 mg/dL is approaching the CVID threshold (<450-500 mg/dL), and CVID can present with initially mild immunoglobulin reductions that worsen over time 1

Warning Signs Present in This Case

This patient meets multiple criteria that warrant immunologic evaluation for inborn errors of immunity: 3

• Recurrent otitis media with complications (TM perforations, bullous myringitis) 3
• Failed vaccine response (non-immune to measles and mumps despite two MMR doses) 1
• Borderline immunoglobulin levels affecting quality of life 1
• Recurrent mucosal infections (oral ulcers, respiratory infections) 1

Connection to EDS/MCAS/POTS Triad

The association between hEDS, MCAS, and immunoglobulin deficiency is well-documented, with 45% of patients with immunoglobulin deficiency having concurrent hEDS/HSD. 4

• In a cohort of 974 patients, 19% had the combination of all three syndromes (hEDS/HSD, MCAD, and immunoglobulin deficiency) 4
• The improvement in ear infections with MCAS treatment (Zyrtec, Pepcid, quercetin) suggests mast cell-mediated inflammation was contributing to infection susceptibility 4
• However, the persistent infections and failed vaccine response indicate an underlying antibody deficiency that requires separate evaluation and treatment 4

Management Based on Findings

If Specific Antibody Deficiency is Confirmed

Patients with documented impaired antibody responses and recurrent infections that negatively affect quality of life should be considered for immunoglobulin replacement therapy, particularly if aggressive antibiotic therapy and prophylaxis fail. 1

• Consider a trial of IVIG or subcutaneous immunoglobulin (SCIG) therapy 1
• Target IgG trough levels >500-600 mg/dL, potentially higher if infections persist 1
• Monitor for anti-IgA antibodies before initiating therapy given the low-normal IgA 1

Antibiotic Prophylaxis Considerations

• If immunoglobulin replacement is not immediately initiated or while awaiting results, consider prophylactic antibiotics for recurrent otitis media 1
• However, given her history of multiple infections despite being a healthcare worker with likely multiple antibiotic courses, prophylaxis alone is unlikely to be sufficient 1

MMR Revaccination Strategy

Do not revaccinate with MMR until the immunologic evaluation is complete and any identified immunodeficiency is treated. 5

• Patients with antibody deficiencies may not respond to revaccination 1
• If immunoglobulin replacement is initiated, she may gain passive immunity to measles and mumps through the donor antibodies in IVIG 1
• Reassess titers 3-6 months after starting immunoglobulin replacement before considering revaccination 5

Otologic Management

Tympanic Membrane Perforation Care

Given the history of TM perforations, strict ear precautions are essential: 6

• Keep ears completely dry - no water exposure during bathing or swimming 6
• Never use ototoxic ear drops (aminoglycosides like gentamicin, tobramycin, neomycin) as they cause permanent sensorineural hearing loss 6
• If topical treatment is needed for infection, use only non-ototoxic preparations such as fluoroquinolone drops 6

ENT Referral

• Refer to otolaryngology for evaluation of current TM status 6
• If perforations are present and the underlying immunodeficiency is treated with dry ears for at least 3 months, consider tympanoplasty 6
• Cartilage reconstruction provides superior outcomes (92.4% success) compared to fascia grafts 6

Oral Ulcer Management

The persistent aphthous ulcers and transient lingual papillitis may be manifestations of the underlying immunodeficiency and could improve with immunoglobulin replacement if indicated. 1

• Mucosal inflammation is common in antibody deficiencies 1
• Document frequency and severity to assess response to any immunologic intervention 1

Critical Pitfalls to Avoid

• Do not dismiss borderline immunoglobulin levels: Values in the low-normal range combined with clinical history and failed vaccine response warrant full evaluation 1
• Do not attribute all symptoms to MCAS/EDS: While these conditions are associated, the failed vaccine response and specific infection pattern indicate a separate immunologic problem requiring distinct treatment 4, 7
• Do not use ototoxic ear preparations: This cannot be overemphasized given her history of TM perforations 6
• Do not delay evaluation: Untreated antibody deficiencies can lead to chronic lung disease, bronchiectasis, and permanent organ damage 1